20245 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
#302Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#303Method of treatment of obesity
#304Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids
#305METABOLISM-IMPROVING AGENT COMPRISING RARE FATTY ACID
#306DHA ENRICHED POLYUNSATURATED FATTY ACID COMPOSITIONS
#307Wound healing composition
#308PYRROLE DERIVATIVES AS ACC INHIBITORS
#309NITRATED-FATTY ACIDS MODULATION OF TYPE II DIABETES
#310Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#311Methods and Nutritional Formulations to Increase the Efficacy and Reduce the Side Effects of Cancer Treatment
#312Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#313Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders
#314Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
#315Oral composition with immunomodulating effect on natural killer cells
#316Compositions for promoting the endogenous self-renewal of stem cells
#317Products And Methods For Reducing Malodor From The Pudendum
#318SYSTEMS AND METHODS FOR LYSOSOME INDUCED IMMUNOGENIC CELL DEATH
#319Compositions of GLP-1 peptides and preparation thereof
#320ACTIVATION OF MITOCHONDRIAL UNCOUPLING AS A THERAPEUTIC INTERVENTION
#321Compositions for reducing mitochondrial dysfunction
#322System and method of estimating livestock weight
#323ROS-RESPONSIVE MICRONEEDLE PATCH FOR ACNE VULGARIS TREATMENT
#324LOW THC HEMP EXTRACT AND METHOD OF TREATMENT OR PREVENTION OF AN EYE DISEASE
#325METHOD OF ADMINISTRATION OF GAMMA HYDROXYBUTYRATE WITH MONOCARBOXYLATE TRANSPORTERS
#326METHOD OF TREATING EPILEPSY OR EPILEPTIC ENCEPHALOPATHY WITH FENFLURAMINE IN PATIENTS WITHOUT PULMONARY HYPERTENSION
#327TREATMENT OF DEGENERATIVE JOINT DISEASE
#328Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof
#329Use of cannabinoids in the treatment of epilepsy
#330Lipid compositions
#331Swine maternal neonatal pheromone
#332METHOD OF TREATING CANCER
#333Formulations Having Anti-inflammatory Activity and Antimicrobial Activity Against Gram-Positive Bacteria
#334DOPAMINERGIC MIMETICS
#335Method for regulating lipolysis and fatty acid oxidative metabolism
#336Pharmaceutical or cosmetic composition for preventing or treating hair loss or promoting hair growth
#337ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID
#338THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
#339ANTISEPTIC COMPOSITONS AND METHODS OF USE
#340COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
#341CHEMICAL MITIGATION OF AFRICAN SWINE FEVER VIRUS AND CLASSICAL SWINE FEVER VIRUS
#342COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO AGING
#343Use of APE1/Ref-1 inhibitors for treatment of retinal diseases
#344Cosmetic compositions
#345Composition for preventing or treating muscle diseases, comprising suberic acid or pharmaceutically acceptable salt thereof as active ingredient
#346MODIFYING TASTE AND SENSORY IRRITATION OF SMOKELESS TOBACCO AND NON-TOBACCO PRODUCTS
#347THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID
#348Composition for promoting skeletal muscle activity via induction of mitochondrial biogenesis comprising of azelaic acid as an active ingredient
#349METHODS AND COMPOSITIONS FOR IDENTIFICATION AND MODULATION OF MICROBIOME BIOCHEMICAL PATHWAYS TO ALTER PHENOTYPE
#350THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF
#351MCT-BASED NUTRITION BLEND FOR PROVIDING HEALTH BENEFITS IN ANIMALS
#352Diabetes treatment regimens using alpha, alpha-substituted long-chain amphipathic carboxylates
#353USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#354METHODS OF ASSESSING FUTURE MEMORY LOSS BY MEASURING POLYUNSATURATED FATTY ACIDS
#355Compositions having antifungal activity
#356Composition and methods of treating acne and photoaging
#357COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE
#358Suppression of Cytokine Release and Cytokine Storm
#359Use of derivatives of polyunsaturated fatty acids as medicaments
#360REVERSIBLY PROTECTED THIOLATED ELECTROPHILIC FATTY ACIDS AS PRODRUGS
#361ABUSE-DETERRENT DRUG FORMULATIONS
#362Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
#363ORAL COMPOSITION OF ANTI-TNF ALPHA ANTIBODIES
#364Antiviral compositions and methods for inactivating non-enveloped viruses using alkyl 2-hydroxycarboxylic acids
#365PRODUCTS AND METHODS FOR REDUCING MALODOR
#366Compounds and methods for treating an epileptic disorder
#367Antibiofilm formulations
#368HAIR RESTORER PREPARATION OR FOOD SUPPLEMENT
#369A Dietary Composition Comprising Plant-Based Sources of Fatty Acids
#370Lipid disulfide prodrugs and uses related thereto
#371Lipid composition for improving body composition during catch-up growth
#372Biomarkers and methods for detection of seizures and epilepsy
#373Composition for prevention, alleviation, and/or treatment of heat illness
#374IONIC LIQUIDS THAT STERILIZE AND PREVENT BIOFILM FORMATION IN SKIN WOUND HEALING DEVICES
#375Therapeutic compositions of decanoic acid and arginine
#376Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
#377HERBAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY
#378COMPOSITIONS AND METHODS FOR PRODUCING ELEVATED AND SUSTAINED KETOSIS
#379Therapeutic use of compounds
#380PELLETED RUMINANT FEED ENRICHED WITH RUMEN-AVAILABLE INGREDIENTS
#381Method for increasing serum adiponectin for treatment and reduction of the risk of cardiovascular, vascular, and related diseases
#382Liposome compositions and methods of use thereof
#383EMULSION AND EMULSION PRECONCENTRATE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACIDS AND USES THEREOF
#384Composition for Preventing or Treating Asthma Comprising Fatty Acid as Active Ingredient
#385Pharmaceutical compositions comprising POH derivatives and methods of use
#386Emulsified oils and blends
#387Therapeutic compositions of undecylenic acid and arginine
#388Nitrated-fatty acids modulation of type II diabetes
#389Capric acid and myristic acid compositions for treating conditions
#390Ketone ester and ketone salt compositions and methods for using the same
#391Composition for use in treating rotavirus infection
#392Compositions and methods that modulate bacteria in a companion animal
#393Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer
#394COMBINATION COMPRISING DECANOIC ACID FOR THE TREATMENT OF EPILEPSY
#395Compounds, compositions and methods for treating oxidative DNA damage disorders
#396Nanoparticles as delivery vehicles of active ingredients and methods for the production thereof
#397Fast-acting plant-based medicinal compounds and nutritional supplements
#398Therapeutic use of compounds
#399CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
#400TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
#401THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#402USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#403Methods of treating chronic dry eye disease using C16:1n7-palmitoleate and derivatives thereof
#404TREATMENT OF RESPIRATORY INFECTION WITH A TLR2 AGONIST
#405Composition for use in the treatment of epilepsy
#406Formulations for oral administration of active agents
#407Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
#408Alleviating oxidative stress disorders with PUFA derivatives
#409Method of glucose-dependent insulinotropic polypeptide (GIP) stabilization
#410Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
#411COMPOSITION COMPRISING AZELAIC ACID OR AS ACTIVE INGREDIENTS FOR MUSCLE STRENGTHENING, DEVELOPMENT, DIFFERENTIATION, REGENERATION OR INHIBITING MUSCLE ATROPHY
#412Pharmaceutical compositions and methods
#413Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions
#414Risperidone-containing patch
#415Metabolism-improving agent comprising rare fatty acid
#416RAPID AND CONTROLLED DELIVERY OF COMPOSITIONS WITH RESTORED ENTOURAGE EFFECTS
#417ABUSE-DETERRENT DRUG FORMULATIONS
#418MUCOSAL IMMUNOSTIMULATOR
#419Combination HIV therapeutic
#420METHODS OF TREATING A MAMMAL SUFFERING FROM OR SUSCEPTIBLE TO AN IMMUNE REACTION TO DRUG TREATMENT
#421Nutritional supplements and therapeutic compositions comprising probiotics
#422SOLID COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF
#423COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILIZATION
#424Health functional food for reducing and preventing capillary hemorrhage
#425Methods and compositions for rapidly decreasing epigenetic age and restoration of more youthful function
#426COMPOSITIONS AND METHODS OF USE
#427METHODS OF USE IN SUPPORT OF PLANNED SUPPLEMENT AND FOOD INGREDIENT PRODUCTS FOR DIAGNOSIS AND TREATMENT OF ANEMIA
#428Cannabidiol (CBD) Formulation Including Caprylic Acid
#429Cosmetic use of arthrofactin
#430NOVEL USES OF PCSK9 INHIBITORS AND RELATED MEDICATIONS
#431Phospholipid compositions and their preparation
#432Pharmaceutical combination comprising a T-type calcium channel blocker
#433COMPOSITIONS AND USES THEREOF FOR THE TREATMENT OF CHRONIC FELINE RESPIRATORY DISORDERS
#434Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof
#435Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
#436(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
#437Anti-inflammatory formulations and uses thereof including a combination of palmitoylethanolamide and plant-based polyphenols
#438Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments
#439USE OF APE/REF-1 REDOX SPECIFIC INHIBITORS FOR TREATING METASTATIC PROSTATE CANCER
#440COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS
#441Compositions containing omega-3 oil and uses thereof
#442Methods for use in support of planned supplement and food ingredient products for diagnosis and treatment of metabolic syndrome
#443Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#444ORAL COMPOSITION WITH IMMUNOMODULATING EFFECT ON NATURAL KILLER CELLS
#445COMPOSITION FOR PROMOTING SKELETAL MUSCLE ACTIVITY VIA INDUCTION OF MITOCHONDRIAL BIOGENESIS COMPRISING OF AZELAIC ACID AS AN ACTIVE INGREDIENT
#446Magnesium threonate compositions and uses thereof
#447Treatment of degenerative joint disease
#448Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
#449Enzyme-rich malt extract (ERME) formulations
#450Compositions and methods for treating acne vulgaris
#451Nutritional composition for improving cell membranes
#452IONIC LIQUIDS THAT STERILIZE AND PREVENT BIOFILM FORMATION IN SKIN WOUND HEALING DEVICES
#453PHARMACEUTICAL COMPOSITION FOR TREATING SKIN ULCERS, INJURIES AND BURNS
#454Reversibly protected thiolated electrophilic fatty acids as prodrugs
#455BIOCONJUGATE MOLECULES WITH BIOLOGICAL AND TECHNO-FUNCTIONAL ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
#456Nutraceutical co-crystal compositions
#457Nitrated-fatty acids modulation of type II diabetes
#458Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#459Hydroxyl compounds and compositions for cholesterol management and related uses
#460ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES
#461Feminine hygiene products
#462NEURODEGENERATIVE DISORDERS AND METHODS OF TREATMENT AND DIAGNOSIS THEREOF
#463Method for preventing, treating, or improving fatty liver by administering effective amounts of azelaic acid to a subject
#464Delaying latency to seizure by combinations of ketone supplements
#465Nutritional composition and infant formula for promoting myelination of the brain
#466Wound healing composition
#467Antimicrobial dental restoratives containing coconut oil and/or derivatives of coconut oil
#468Composition comprising combination of TRH analog with arundic acid, and pharmaceutically acceptable salt of arundic acid
#469Compositions for Diagnosis and Treatment of Inflammation
#470MCT-BASED NUTRITION BLEND FOR PROVIDING HEALTH BENEFITS IN COMPANION ANIMALS
#471Neurodegenerative disorders and muscle diseases implicating PUFAs
#472Combination therapy with an anti-axl antibody-drug conjugate
#473COMPOSITION FOR USE IN TREATING ROTAVIRUS INFECTION
#474Methods of treatment using a lipid extract of seeds concentrated in its unsaponifiable fraction
#475Extracts and isolated compounds from for treatment of ulcer
#476METHODS AND COMPOSITIONS FOR TREATMENT OF LIPID STORAGE DISORDERS
#477Compositions for Diagnosis and Treatment of Anemia
#478Lipid comprising docosapentaenoic acid
#479BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS
#480NUTRITIONAL BOLUS FOR ANIMALS
#481Composition for promoting ketone body production
#482Methods of detecting and treating a tumor expressing pT346 PDK1
#483EUKARYOTIC MICROORGANISMS FOR PRODUCING LIPIDS AND ANTIOXIDANTS
#484ANGPTL8-binding agents and methods of use thereof
#485Compounds and methods for treating an epileptic disorder
#486Protective Effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC Against Drugs that Cause Channelopathies
#487Lipid composition for use in infants and young children for promoting gut comfort and optimal fat and calcium absorption
#488USE OF APE1/REF-1 INHIBITORS IN COMBINATION THERAPIES FOR TREATMENT OF CANCER
#48910-hydroxystearic acid compositions
#490Highly loaded metal oxide materials by self-assembly for extended biologically active molecule release in medical and dental applications
#491Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration
#492Fast-acting plant-based medicinal compounds and nutritional supplements
#493FATTY ACID COMPOSITION AND PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
#494Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
#495Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
#496Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening
#497Method of treatment of obesity
#498NUTRITIONAL COMPOSITIONS AND THEIR USE
#499Lipid comprising long chain polyunsaturated fatty acids
#500Composition and method for pretreating cancer
#501Oil foamable carriers and formulations
#502CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES
#503GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#504Antibiotic Kit and Composition and Uses Thereof
#505Antibiotic kit and composition and uses thereof
#506Composition for and method to increase serum adiponectin and reduce body fat
#507Fatty-acid based particles
#508ALLEVIATING OXIDATIVE STRESS DISORDERS WITH PUFA DERIVATIVES
#509IMPAIRED ENERGY PROCESSING DISORDERS AND MITOCHONDRIAL DEFICIENCY
#510Lipid scavenging in Ras cancers
#511Antimicrobial compositions and uses thereof
#512Cosmetic compositions
#513COMPOSITIONS AND METHODS FOR MOOD STABILIZATION
#514FATTY ACID TREATMENT FOR CARDIAC PATIENTS
#515Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
#516Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#517Composition having antifungal activity
#518Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
#519Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid
#520Lipid disulfide prodrugs and uses related thereto
#521POLYTHERAPY MODULATING CATHELICIDIN GENE EXPRTESSION MODULATION FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER CONDITIONS
#522SYNTHETIC LETHALITY AND THE TREATMENT OF CANCER
#523Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#524COMPOSITIONS AND METHODS FOR INDUCING SATIETY AND TREATING NON-INSULIN DEPENDENT DIABETES MELLITUS, PRE-DIABETIC SYMPTOMS, INSULIN RESISTANCE AND RELATED DISEASE STATES AND CONDITIONS
#525Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position
#526COMPOSITIONS CONTAINING PHEROMONES FOR TREATING BEHAVIOURAL OR MEDICAL PROBLEMS LINKED TO THE STRESS OF NON-HUMAN MAMMALS
#527Composition for preventing and/or treating cardiovascular and cerebrovascular diseases
#528Autophage activating resveratrol topical composition for skin improvement and treatment
#529Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
#530Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
#531DOPAMINERGIC MIMETICS
#532Use of cannabinoids in the treatment of epilepsy
#533FIXED DOSE FORMULATIONS
#534Compositions and methods for mitigating methanogenesis in animals
#535Delivery system comprising a core and a digestible polymer shell
#536Methods of treating muscular dystrophy
#537Injectable composition; method for preparing said composition; use of said composition
#538Compositions and methods of treating acne and photoaging
#539Bioeffective krill oil compositions
#540Compositions for diagnosis and treatment of type 2 diabetes
#541SKIN BARRIER ENHANCING ARTICLE AND MANUFACTURING METHOD
#542Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#543Compositions and methods for treating retinopathy
#544Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
#545Compositions and methods for diagnosis and treatment of metabolic syndrome
#546Formulations for epidermal repair
#547COMPOSITIONS COMPRISING MEDIUM CHAIN TRIGLYCERIDES
#548SUPPLEMENTAL HEALTH BEVERAGE AND METHOD
#549Methods of treating muscular dystrophy
#550Lipofullerene-saccharide conjugates and their use as antimetastatic agents for the inhibition of mammalian neoplasms
#551NITRATED-FATTY ACIDS MODULATION OF TYPE II DIABETES
#552Lipid formulations containing bioactive fatty acids
#553Highly stable non-vesicular nanoparticles and application thereof in treating microbial infection
#554Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
#555Antimicrobial and antiviral composition
#556NEUROTRANSMITTER AND BRAIN MODULATING ORAL DELIVERY SYSTEM FOR ENHANCEMENT OF COGNITIVE FUNCTIONS AND ENERGY
#557Compounds and methods for treating an epileptic disorder
#558Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
#559PROTOCOL FOR HEALTH REHABILITATION
#560NEURODEGENERATIVE DISORDERS AND METHODS OF TREATMENT AND DIAGNOSIS THEREOF
#561COMPOSITIONS AND METHODS FOR TREATING, PREVENTING, OR ALLEVIATING OBESITY OR RELATED DISEASES
#562Method of administration of gamma hydroxybutyrate with monocarboxylate transporters
#563Methods of assessing future memory loss by measuring polyunsaturated fatty acids
#564Healthful supplements
#565Bioeffective krill oil compositions
#566Method for prolonging the over survival of a cancer patient
#567Compositions and methods for diagnosis and treatment of inflammation
#568Compositions and methods for diagnosis and treatment of anemia
#569METHODS AND COMPOSITIONS FOR TREATING NEPHROPATHY
#570Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof
#571COMPOSITIONS AND METHODS THAT MODULATE BACTERIA IN A COMPANION ANIMAL
#572Compositions and methods that modulate cholesterol in a companion animal
#573Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
#574Skin barrier repair and maintenance composition
#575Artificial sebum film and method of producing same
#576PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION
#577METHOD OF TREATING INFLAMMATION USING NATURAL COMPOUNDS AND/OR DIET
#578Combination HIV therapeutic
#579Methods and compositions for treating schizophrenia
#580Nitrated-fatty acids modulation of type II diabetes
#581BIOCONJUGATE MOLECULES WITH BIOLOGICAL AND TECHNO-FUNCTIONAL ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
#582METHOD FOR IMPROVING BLADDER FUNCTION
#583Pharmaceutical formulations containing lipoic acid derivatives
#584(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use
#585Soap compositions and methods
#586MUCOSAL IMMUNOSTIMULATOR
#587Transplantation Adjuvant in Cell Therapy Using Neural Progenitor Cells
#588Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices
#589GEL COMPOSITION FOR TREATMENT OF COMMON ACNE COMPRISING A COMBINATION OF BENZOYL PEROZIDE AND ADAPALENE AND/OR ADAPALENE SALT
#590Additives for animal feed
#591COMPOSITIONS AND METHODS FOR COGNITIVE HEALTH AND MEMORY
#592Use of derivatives of polyunsaturated fatty acids as medicaments
#593COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF
#594Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease
#595LIQUID NUTRITIONAL FORMULA FOR TYROSINEMIA PATIENTS
#596Compounds, compositions and methods useful for cholesterol mobilization
#597Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
#598Liposome structures and methods of use thereof
#599Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#600SKIN LIPIDOMIC ASSAY